At Onyx, our success begins with our employees. The progress we've made reflects the talents of the individuals who have come together to develop possible new therapeutics for treating cancer.

Onyx is a biopharmaceutical company developing innovative therapies that target the molecular mechanisms that cause cancer. The company is developing Nexavar®, a small molecule drug, with Bayer Pharmaceuticals Corporation.  Nexavar is currently approved in the U.S. (view press release) and the EU (view press release) for the treatment of patients with advanced kidney cancer, as well as in the U.S. (view press release) and the EU  (view press release) for the treatment of patients with liver cancer. In addition, we have a small molecule cell cycle inhibitor resulting from collaboration with Pfizer Inc. in early clinical development.

We are proud of the dedication and accomplishments of all our employees, and we have demonstrated our commitment to them by fostering a working environment that is entrepreneurial, challenging and friendly. Our environment is one where everyone can learn, grow and succeed.

Onyx is proud to be an equal opportunity employer who respects individual differences and recognizes each employee as an integral member of our company. We offer a competitive comprehensive compensation and benefit program.

If you want to become part of our team, look at our open positions and send us your resume for any position you feel matches your background and experience.